J Rubió-Casadevall1, A M Hernandez-Pujol2, M C Ferreira-Santos3, G Morey-Esteve2, L Vilardell3, G Osca-Gelis4, N Vilar-Coromina5, R Marcos-Gragera3. 1. Medical Oncology Department, Catalan Institute of Oncology, Girona, Spain; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain; Faculty of Medicine, University of Girona (UdG), Spain. Electronic address: jrubio@iconcologia.net. 2. Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan Department of Health, Government of Catalonia, Catalan Institute of Oncology, Girona, Spain. 3. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan Department of Health, Government of Catalonia, Catalan Institute of Oncology, Girona, Spain. 4. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan Department of Health, Government of Catalonia, Catalan Institute of Oncology, Girona, Spain; Research Group on Statistics, Econometrics and Health (GRECS), University of Girona (UdG), Spain. 5. Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute (IDIBGI), Girona, Spain; Faculty of Medicine, University of Girona (UdG), Spain; Dermatology Unit, University Hospital Josep Trueta, Catalan Institute of Health, Girona, Spain.
Abstract
INTRODUCTION: We present an epidemiological study focused on Non-melanoma skin cancers (NMSC), including squamous cell carcinoma (SCC), basal cell carcinoma (BCC), Merkel cell carcinoma (MCC), dermatofibrosarcoma protuberans (DFS) and adnexal and skin appendages neoplasm (ASAN), a neoplasm understudied in cancer registries. MATERIAL AND METHODS: We analyze trends of incidence and survival of NMSC registered with the Cancer Registry of Girona, Spain. RESULTS: We found 14389 cases of NMSC, accounting 3,474 SCC, 10729 BCC, 33 MCC, 61 DFSP and 71 ASAN. Incidence increased significantly in SCC and BCC with annual percentage of change of 1.6 and 1.5, respectively, but not in MCC, DFS or ASAN. Five-year relative survival for both sexes was 90.1% in SCC, 99.8% in BCC, 44.2% in MCC, 93.7% in DFS and 84% in ASAN. CONCLUSIONS: Our study confirms the increasing incidence and good survival of SCC and BCC and enhances knowledge on the epidemiology of the less incidental NMSC. Copyright Â
INTRODUCTION: We present an epidemiological study focused on Non-melanoma skin cancers (NMSC), including squamous cell carcinoma (SCC), basal cell carcinoma (BCC), Merkel cell carcinoma (MCC), dermatofibrosarcoma protuberans (DFS) and adnexal and skin appendages neoplasm (ASAN), a neoplasm understudied in cancer registries. MATERIAL AND METHODS: We analyze trends of incidence and survival of NMSC registered with the Cancer Registry of Girona, Spain. RESULTS: We found 14389 cases of NMSC, accounting 3,474 SCC, 10729 BCC, 33 MCC, 61 DFSP and 71 ASAN. Incidence increased significantly in SCC and BCC with annual percentage of change of 1.6 and 1.5, respectively, but not in MCC, DFS or ASAN. Five-year relative survival for both sexes was 90.1% in SCC, 99.8% in BCC, 44.2% in MCC, 93.7% in DFS and 84% in ASAN. CONCLUSIONS: Our study confirms the increasing incidence and good survival of SCC and BCC and enhances knowledge on the epidemiology of the less incidental NMSC. Copyright Â
Authors: A F Bais; R M Lucas; J F Bornman; C E Williamson; B Sulzberger; A T Austin; S R Wilson; A L Andrady; G Bernhard; R L McKenzie; P J Aucamp; S Madronich; R E Neale; S Yazar; A R Young; F R de Gruijl; M Norval; Y Takizawa; P W Barnes; T M Robson; S A Robinson; C L Ballaré; S D Flint; P J Neale; S Hylander; K C Rose; S-Å Wängberg; D-P Häder; R C Worrest; R G Zepp; N D Paul; R M Cory; K R Solomon; J Longstreth; K K Pandey; H H Redhwi; A Torikai; A M Heikkilä Journal: Photochem Photobiol Sci Date: 2018-02-14 Impact factor: 3.982
Authors: Rossybelle P Amorrortu; Yayi Zhao; Sandra Stewart; Kavita M Ghia; Vonetta L Williams; Vernon K Sondak; Kenneth Y Tsai; Javier Pinilla; Julio Chavez; Dana E Rollison Journal: J Cancer Res Clin Oncol Date: 2022-08-13 Impact factor: 4.322
Authors: Christopher K Bichakjian; Thomas Olencki; Sumaira Z Aasi; Murad Alam; James S Andersen; Rachel Blitzblau; Glen M Bowen; Carlo M Contreras; Gregory A Daniels; Roy Decker; Jeffrey M Farma; Kris Fisher; Brian Gastman; Karthik Ghosh; Roy C Grekin; Kenneth Grossman; Alan L Ho; Karl D Lewis; Manisha Loss; Daniel D Lydiatt; Jane Messina; Kishwer S Nehal; Paul Nghiem; Igor Puzanov; Chrysalyne D Schmults; Ashok R Shaha; Valencia Thomas; Yaohui G Xu; John A Zic; Karin G Hoffmann; Anita M Engh Journal: J Natl Compr Canc Netw Date: 2018-06 Impact factor: 12.693
Authors: Monica Ospina-Romero; M Maria Glymour; Eleanor Hayes-Larson; Elizabeth Rose Mayeda; Rebecca E Graff; Willa D Brenowitz; Sarah F Ackley; John S Witte; Lindsay C Kobayashi Journal: JAMA Netw Open Date: 2020-11-02